BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8370072)

  • 1. Bidirectional modulation of human B cell stimulation by activated T cells.
    Hirohata S; Shinohara S
    Cell Immunol; 1993 Sep; 150(2):257-68. PubMed ID: 8370072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell regulation of human B cell proliferation and differentiation. Regulatory influences of CD45R+ and CD45R- T4 cell subsets.
    Hirohata S; Lipsky PE
    J Immunol; 1989 Apr; 142(8):2597-607. PubMed ID: 2564858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of CD40-CD40 ligand interactions in suppression of human B cell responsiveness by CD4+ T cells.
    Hirohata S
    Cell Immunol; 1997 Nov; 182(1):20-8. PubMed ID: 9427806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of human B cell responsiveness by CD4+ T cells does not involve CD95-CD95 ligand interactions.
    Hirohata S
    Cell Immunol; 1997 Nov; 181(2):182-91. PubMed ID: 9398405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulus-dependent modulation of human B cell function by T cell clones.
    Patel SS; Thiele DL; Lipsky PE
    Cell Immunol; 1993 Feb; 146(2):362-81. PubMed ID: 8174175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell-dependent activation of B cell proliferation and differentiation by immobilized monoclonal antibodies to CD3.
    Hirohata S; Jelinek DF; Lipsky PE
    J Immunol; 1988 Jun; 140(11):3736-44. PubMed ID: 2967324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency of human B cells that differentiate in response to anti-CD3-activated T cells.
    Amoroso K; Lipsky PE
    J Immunol; 1990 Nov; 145(10):3155-61. PubMed ID: 2146316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of CD27 expression on subsets of mature T-lymphocytes.
    Hintzen RQ; de Jong R; Lens SM; Brouwer M; Baars P; van Lier RA
    J Immunol; 1993 Sep; 151(5):2426-35. PubMed ID: 7689607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of B cell expression of DNA polymerase alpha by CD4+ suppressor T cells.
    Hirohata S
    Cell Immunol; 1993 Aug; 150(1):159-67. PubMed ID: 8102086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD31, a novel cell surface marker for CD4 cells of suppressor lineage, unaltered by state of activation.
    Torimoto Y; Rothstein DM; Dang NH; Schlossman SF; Morimoto C
    J Immunol; 1992 Jan; 148(2):388-96. PubMed ID: 1345920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.
    Ahn JS; Krishnadas DK; Agrawal B
    Int Immunol; 2007 Mar; 19(3):227-37. PubMed ID: 17289657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel immunoregulatory functions of phenotypically distinct subpopulations of CD4+ cells in the human neonate.
    Clement LT; Vink PE; Bradley GE
    J Immunol; 1990 Jul; 145(1):102-8. PubMed ID: 1694200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Both CD45RA+ and CD45RA- subpopulations of CD8+ T cells contain cells with high levels of lymphocyte function-associated antigen-1 expression, a phenotype of primed T cells.
    Okumura M; Fujii Y; Inada K; Nakahara K; Matsuda H
    J Immunol; 1993 Jan; 150(2):429-37. PubMed ID: 7678274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of proliferation and differentiation during early T cell development by anti-transferrin receptor antibody.
    Brekelmans P; van Soest P; Leenen PJ; van Ewijk W
    Eur J Immunol; 1994 Nov; 24(11):2896-902. PubMed ID: 7957580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of nondividing high rate Ig-secreting plasma cells in cultures of human B cells stimulated with anti-CD3-activated T cells.
    Vernino L; McAnally LM; Ramberg J; Lipsky PE
    J Immunol; 1992 Jan; 148(2):404-10. PubMed ID: 1530861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features.
    D'Arena G; Musto P; Cascavilla N; Di Giorgio G; Fusilli S; Zendoli F; Carotenuto M
    Haematologica; 1998 Mar; 83(3):197-203. PubMed ID: 9573672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble, but not immobilized, anti-IgM antibody inhibits post-activation events leading to T-cell-dependent B-cell differentiation.
    Zamorano J; Rivas D; Gayo A; Mozo L; GutiƩrrez C
    Immunology; 1995 Jun; 85(2):241-7. PubMed ID: 7642212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
    Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
    Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular basis of Trypanosoma cruzi-induced immunosuppression. Altered expression by activated human lymphocytes of molecules which regulate antigen recognition and progression through the cell cycle.
    Kierszenbaum F; Moretti E; Sztein MB
    Biol Res; 1993; 26(1-2):197-207. PubMed ID: 7670532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential in vitro activation of CD8-CD4+ and CD4-CD8+ T lymphocytes by combinations of anti-CD2 and anti-CD3 antibodies.
    Yang SY; Rhee S; Welte K; Dupont B
    J Immunol; 1988 Apr; 140(7):2115-20. PubMed ID: 3258328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.